Congress ticker disclosure profile

As of July 3 at 11:44 PM EDT

Public STOCK Act rows mentioning

BKDT

A factual page for public Congressional disclosures that reference BKDT. Veridion shows filed rows, disclosed amount ranges, dates, and source links. It does not imply motive or wrongdoing.

90d rows

0

Feed lifetime

15

Member filers

1

Disclosed ranges

Amount not disclosed

Most active member desks

14 buys vs 1 sells

Latest source-stamped receipts

Latest trade Jan 21, 2026

DateMemberActionAmountFiledReceipt
Jan 21, 2026Michael T. McCaulBuyAmount not disclosedDate not disclosedOpen card
Sep 29, 2025Michael T. McCaulBuyAmount not disclosedDate not disclosedOpen card
Jul 18, 2025Michael T. McCaulBuyAmount not disclosedDate not disclosedOpen card
Apr 30, 2025Michael T. McCaulBuyAmount not disclosedDate not disclosedOpen card
Jan 21, 2025Michael T. McCaulBuyAmount not disclosedDate not disclosedOpen card
Mar 26, 2024Michael T. McCaulBuyAmount not disclosedDate not disclosedOpen card
Jan 2, 2024Michael T. McCaulBuyAmount not disclosedDate not disclosedOpen card
Sep 26, 2023Michael T. McCaulBuyAmount not disclosedDate not disclosedOpen card
Jul 26, 2023Michael T. McCaulBuyAmount not disclosedDate not disclosedOpen card
Jun 23, 2023Michael T. McCaulBuyAmount not disclosedDate not disclosedOpen card
Jun 12, 2023Michael T. McCaulBuyAmount not disclosedDate not disclosedOpen card
Oct 25, 2022Michael T. McCaulBuyAmount not disclosedDate not disclosedOpen card
Jul 18, 2022Michael T. McCaulBuyAmount not disclosedDate not disclosedOpen card
Jul 12, 2021Michael T. McCaulBuyAmount not disclosedDate not disclosedOpen card
Jul 11, 2019Michael T. McCaulSellAmount not disclosedDate not disclosedOpen card

Source creed

This page is assembled from public STOCK Act disclosure records in the Veridion warehouse. 0 of 15 filed rows include disclosed amount ranges (0.0%). Rows without ranges stay labeled. Identification only; it does not imply motive or wrongdoing.

Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.